Harvard Bioscience Inc expected to post earnings of 6 cents a share - Earnings Preview

Harvard Bioscience

01/11/2021 18:24

* Harvard Bioscience Inc  HBIO.OQ   HBIO.O  is expected to show
a rise in quarterly revenue when it reports  results on November
3. 
* The Holliston, Massachusetts-based company is expected to
report  a 16.1% increase in revenue to $27.91 million from
$24.04 million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Harvard Bioscience Inc
is for earnings of 6 cents per share. For the same quarter last
year, the company reported earnings of 4 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Harvard
Bioscience Inc is $10​, about 24.7% above​ its last closing
price of $7.53. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 302021   0.06        0.06       0.06      Met     -5.3
 Mar. 312021   0.03        0.03       0.05      Beat    50
 Dec. 312020               0.07       0.08      Beat    23.1​
 Sep. 302020   0.03        0.04       0.04      Met     14.3
 ​​Jun.        -0.01       -0.01      0.05      Beat    600
 302020                                                 
 Mar. 312020   0.03        0.03       -0.01     Missed  -130​
 Dec. 312019   0.09        0.09       0.08      Missed  -7.7
 Sep. 302019   0.06        0.05       0.04      Missed  -25
 This summary was machine generated November 1 at 18:24 GMT.  All
figures in US dollars unless otherwise stated